2 weeks ago

Beam Therapeutics Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 in Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting

Share this!

Read Entire Article
  1. Homepage
  2. Finance
  3. Beam Therapeutics Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 in Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting

Related

Mullen Automotive's Bollinger Motors Expands Midwest Reach With Broadway Ford Truck Center Dealership

Mullen Automotive's Bollinger Motors Expands Midwest Reach W...

2 weeks ago
Why Shell Stock Is Rising

Why Shell Stock Is Rising

2 weeks ago
Why Bilibili Shares Are Exploding Higher

Why Bilibili Shares Are Exploding Higher

2 weeks ago

© NewsMage 2024. All rights are reserved

About Us · Contact Us · Follow Us ·